Swedish Sigrid Therapeutics raises $4 million to tap into booming obesity and diabetes market

Sigrid Therapeutics is dedicated to revolutionizing obesity and diabetes management through its innovative SiPore® technology. Here are details of Sigrid‘s latest funding round :


🚀 Launch


🏭 Industry



Sana Alajmovic (Co-Founder & CEO)

💸 Funding & Investors

INVESTMENT (October 2023) $4 million
INVESTORS (October 2023)

🎯 Funding purpose

The funds will be instrumental in accelerating the commercialisation of SiPore® across diverse markets, including medical devices, food supplements, veterinary, and oral health. 

🌐 Country HQ

Sweden (Stockholm)

Leave a Reply

Your email address will not be published.